Self-Management for Amputee Rehabilitation Using Technology (SMART)

October 7, 2021 updated by: William C. Miller, University of British Columbia

Self-Management for Amputee Rehabilitation Using Technology (SMART) Phase 2

The purpose of this study is to determine the effect of 6 weeks of the SMART Program on the walking capacity and confidence of individuals with unilateral lower limb amputation (LLA). Our primary hypothesis is that SMART can improve walking capacity in individuals with LLA. Our secondary hypothesis is that SMART can improve ambulation confidence, body function, depression, body image, pain, balance confidence, activities of daily living, satisfaction with life and habit formation for skin monitoring and prosthetic cleaning in individuals with LLA. A post-intervention one on one interview will be conducted to understand SMART acceptability. The entirety of the study, including intervention administration, assessment, and interviews will be conducted online.

Study Overview

Detailed Description

Participants will receive an online link to access the SMART platform. Online training on using the SMART platform will be provided for participants. Participants will be asked to complete one education module per week at their own convenience and weekly online meetings with a peer over the 6-week intervention period. The educational modules include psychological adaptation, residual limb management, nutrition/weight control, managing a prosthetic limb, managing chronic conditions and enhancing mobility. The modules include instructional movies, goal setting logs, and quizzes. A module can be stopped or "re-wound" at any point, and the participant's place and work-to-date is automatically saved. The SMART platform will be asynchronously monitored through a web portal by the trainer, who will be a PhD candidate in Rehabilitation Sciences and observe participant progress and provide feedback if required. If there is no online activity within a 7-day (consecutive) period, the trainer will contact the participant to inquire the reasons for inactivity and troubleshoot any problems including technical issues. Clinical outcomes measures will be collected at two timepoints (T1 & T2). A post-intervention one on one interview will be conducted to explore SMART acceptability.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z2G9
        • GF Strong Rehabilitation Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 100 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. adults who are 19 years of age or older.
  2. individuals who are post unilateral transtibial/transfemoral amputation and casted an initial prosthesis within the past year.
  3. English speaking.
  4. living in British Columbia or Ontario, Canada.
  5. have access to an internet connectable device (e.g., computer or tablet)

Exclusion Criteria:

1) people who are unable to use SMART program (e.g., visual, auditory, cognitive, or physical impairments)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DEVICE_FEASIBILITY
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: SMART & Peer Support
Participants will complete a 6-week tablet-based education program for individuals with LLA that will provide them with self-management education.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed Up & Go Test (TUG)
Time Frame: 6 weeks
Functional assessment of walking capacity measured in seconds over 3 meters walkway
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ambulatory Self-Confidence Questionnaire (ASCQ)
Time Frame: 6 weeks
22-item questionnaire where participants are asked to rate questions on a scale from 0 (not confident at all) to 10( extremely confident)
6 weeks
The Center for Epidemiologic Studies Depression Scale (CES-D)
Time Frame: 6 weeks
Self-rating measure assessing depression, with final scores ranging from 0 to 60, with total score above 23 indicating clinical depression
6 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Revised Amputee Body Image Scale (ABIS-R)
Time Frame: 6 weeks
14-item measure that evaluates self perception of body image in individuals with LLA, exploring their feelings about physical appearance, levels of anxiety and comfort in various social situations after amputation. Total ABIS-R score ranges from 20-100, greater score indicates higher body image disturbance.
6 weeks
Pain Questionnaire
Time Frame: 6 weeks
A questionnaire will be used to assess both pain frequency and intensity over one week in three categories: residual limb pain (pain in the above portion of the amputated site), phantom limb pain (pain in the missing portion of the limb), and the nonpainful phantom limb sensation (sensations in the missing portion of the limb which were not painful)
6 weeks
Activities Specific Balance Confidence Scale (ABC).
Time Frame: 6 weeks
16-item self-report measure that assesses perceived balance confidence, which is important for mobility. Total ABC score ranges from 0-100, with greater score indicating higher levels of balance confidence.
6 weeks
Barthel Index (BI)
Time Frame: 6 weeks
10-item scale that measures independence in self-care and mobility
6 weeks
Satisfaction With Life Scale (SWLS)
Time Frame: 6 weeks
5-item measure scored on a Likert scale from 1 (strongly disagree) to 7 (strongly agree).
6 weeks
Self-Report Habit Index (SRHI).
Time Frame: 6 weeks
12-item questionnaire based on the 7-point Likert scale with the range of total score between 0 to 84, which higher scores show the stronger habit strength
6 weeks
Short Musculoskeletal Function Assessment (SMFA)
Time Frame: 6 weeks
Items 1-34 of an assessment of difficulties with daily activities and experiencing problems because of injury.
6 weeks
Physical Activity Identity (PAI)
Time Frame: 6 weeks
9-item questionnaire used to assess the extent physical activity is integrated within the concept of self.
6 weeks
Patient Education Material Assessment Tool (PEMAT)
Time Frame: 6 weeks
26-item questionnaire used to assess the understandability and actionability of an educational intervention from the perspective of participants.
6 weeks
Perceived Usefulness Questionnaire (PUQ)
Time Frame: 6 weeks
17-item questionnaire used to assess the perceived usefulness, ease-of-use, intention to continue usage, and satisfaction of SMART.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 26, 2021

Primary Completion (ACTUAL)

August 31, 2021

Study Completion (ACTUAL)

August 31, 2021

Study Registration Dates

First Submitted

October 7, 2019

First Submitted That Met QC Criteria

October 8, 2019

First Posted (ACTUAL)

October 9, 2019

Study Record Updates

Last Update Posted (ACTUAL)

October 15, 2021

Last Update Submitted That Met QC Criteria

October 7, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Unilateral Trans Tibial/Femoral Lower Limb Amputation

Clinical Trials on Self-Management for Amputee Rehabilitation using Technology [SMART]

3
Subscribe